Effect of intraarticular propolis in an experimental septic arthritis model

Journal of Pediatric Orthopaedics Part B

Volumn 20, Issue 1, 2011, Pages 8-13

  Oner, Mithat ^a   Kafadar, Ibrahim ^a   Guney, Ahmet ^a   Halici, Mehmet ^a   Deniz, Kemal ^a   Turk, Yildirim ^a   Argun, Mahmut ^a  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

antibiotic; experimental septic arthritis; intraarticular propolis

Indexed keywords

CEFAZOLIN; PROPOLIS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL ARTHRITIS; CARTILAGE CELL; CARTILAGE MATRIX; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; DRUG SAFETY; EXPERIMENTAL RABBIT; HISTOPATHOLOGY; KNEE ARTHRITIS; NONHUMAN; PANNUS; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SCORING SYSTEM; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, INFECTIOUS; CARTILAGE, ARTICULAR; CEFAZOLIN; CHONDROCYTES; DISEASE MODELS, ANIMAL; INJECTIONS, INTRA-ARTICULAR; MICROSCOPY, ELECTRON, SCANNING; PROPOLIS; RABBITS; STIFLE; TREATMENT OUTCOME;

EID: 78650511100     PISSN: 1060152X     EISSN: 14735865     Source Type: Journal    
DOI: 10.1097/BPB.0b013e32833faca8     Document Type: Article

References (27)

1. Klein RS. Joint infection, with consideration of underlying disease and sources of bacteremia in hematogenous infection. Clin Geriatr Med 1988; 4:375-394.
2. Morgan DS, Fisher D, Merianos A, Currie BJ. An 18 year clinical review of septic arthritis from tropical Australia. Epidemiol Infect 1996; 117:423-428.
3. Deesomchok U, Tumrasvin T. Clinical study of culture-proven cases of nongonococcal arthritis. J Med Assoc Thai 1990; 73:615-623.
4. Shirtlif ME, Mader JT. Acute septic arthritis. Clin Microbiol Rev 2002; 15:527-544.
5. Nade S. Septic arthritis. Best Pract Res Clin Rheumatol 2003; 17:183-200.
6. Pioro MH, Mandell BF. Septic arthritis. Rheum Dis Clin North Am 1997; 23:239-258.
7. Riegels-Nielsen P, Frimodt-Moller N, Sorensen M, Jensen S. Antibiotic treatment insufficient for established septic arthritis. Acta Orthop Scand 1989; 60:113-115.
8. Smith RL, Schurman DJ, Kajiyama G, Mell M, Gilkerson E. The effect of antibiotics on the destruction of cartilage in experimental infectious arthritis. J Bone Joint Surg Br 1987; 69:1063-1068.
9. Volpert R, Elstern EF. Biochemical activities of propolis extracts. Standardization and antioxidative properties of ethanolic and aqueous derivatives. Z Naturforsch 1993; 48:851-857.
10. Khayyal MT, el-Ghazaly MA, el-Khatib AS. Mechanisms involved in the anti-inflammatory effect of propolis extract. Drugs Exp Clin Res 1993; 19:197-203.
11. Kujumgiev A, Tsvetkova I, Sekledjieva Y, Bankova V, Christov R, Popov S. Antibacterial, antifungal and antiviral activity of propolis of different geographic origin. J Ethnopharmacol 1999; 64:235-240.
12. Krol W, Scheller S, Shani J, Pietsz G, Czuba Z. Synergistic effect of ethanol extract of propolis and antibiotics in the growth of Staphylococcus aureus. Drug Res 1993; 43:607-609.
13. Lua LC, Chenb YW, Choua CC. Antibacterial activity of propolis against Staphylococcus aureus. Int J Food Microbiol 2005; 102:213-220.
14. Cardilea V, Panicob A, Gentileb B, Borrellic F, Russod A. Effect of propolis on human cartilage and chondrocytes. Life Sci 2003; 73:1027-1035.
15. Puliti M, von Hunolstein C, Bistoni F, Castronari R, Orefici G, Tissi L. Role of macrophages in experimental group B streptococcal arthritis. Cell Microbiol 2002; 4:691-700.
16. Salter RB, Bell RS, Keeley FW. The protective effect of continuous passive motion on living articular cartilage in acute septic arthritis: An experimental investigation in the rabbit. Clin Orthop 1981; 159:223-247.
17. Kaandorp CJ, Krijnen P, Moens HJ, Habbema JD, Van Schaardenburg D. The outcome of bacterial arthritis: A prospective community-based study. Arthritis Rheum 1997; 40:884-892.
18. Marcucci MC. Propolis: Chemical composition, biological properties and therapeutic activity. Apidologie 1995; 26:83-99.
19. Nieva Moreno MI, Isla MI, Cudmani NG, Vattuone MA, Sampietro AR. Screening of antibacterial activity of Amaiche del Valle (Tucuma'r, Argentina) propolis. J Ethnopharmacol 1999; 68:97-102.
20. Mirzoeva OK, Grishanin RN, Calder PC. Antimicrobial action of propolis and some of its components: The effects on growth, membrane potential and motility of bacteria. Microbiol Res 1997; 152:239-246.
21. Popovaa M, Silici S, Kaftanoglu O, Bankovaa V. Antibacterial activity of Turkish propolis and its qualitative and quantitative chemical composition. Phytomedicine 2005; 12:221-228.
22. Scazzocchioa F, D'Auriaa FD, Alessandrinia D, Pantanella F. Multifactorial aspects of antimicrobial activity of propolis. Microbiol Res 2006; 161:327-333.
23. Fernandes Júnior A, Balestrin EC, Betoni JE, Orsi Rde O, da Cunha Mde L, Montelli AC. Propolis: Anti-Staphylococcus aureus activity and synergism with antimicrobial drugs. Mem Inst Oswaldo Cruz 2005; 100:563-566.
24. Onlen Y, Duran N, Atik E, Savas L, Altug E, Yakan S, Aslantas O. Antibacterial activity of propolis against MRSA and synergism with topical mupirocin. J Altern Complement Med 2007; 13:713-718.
25. Nostro A, Cellini L, Di Bartolomeo S, Cannatelli MA, Di Campli E, Procopio F, et al. Effects of combining extracts (from propolis or Zingiber officinale) with clarithromycin on Helicobacter pylori. Phytother Res 2006; 20:187-190.
26. Stepanović S, Antić N, Dakić I, Svabić -Vlahović M. In vitro antimicrobial activity of propolis and synergism between propolis and antimicrobial drugs. Microbiol Res 2003; 158:353-357.
27. Krol W, Scheller S, Shani J, Pietsz G, Czuba Z. Synergistic effect of ethanolic extract of propolis and antibiotics on the growth of Staphylococcus aureus. Arzneimittelforschung 1993; 43:607-609.